会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Indolomorphinan derivative and agent for curing and preventing cerebral
disorder
    • 吲哚并吗啡喃衍生物和治疗和预防脑病的药剂
    • US6156762A
    • 2000-12-05
    • US142794
    • 1998-09-24
    • Hiroshi NagaseYoshifumi ImamuraJunichi HirokawaSusumu MatsudaYasushi Miyauchi
    • Hiroshi NagaseYoshifumi ImamuraJunichi HirokawaSusumu MatsudaYasushi Miyauchi
    • C07D489/00C07D491/18C07D491/20A61K31/485C07D489/10
    • C07D489/00
    • The present invention provides an indolomorphinan derivative or a pharmacologically acceptable acid addition salt thereof, and an agent for curing and preventing cerebral disorders composed of the derivative and salt thereof, which is represented by the following formula (I): ##STR1## [wherein R.sup.1 represents cyclopropylmethyl or the like; R.sup.2 and R.sup.3 each represent hydroxy methoxy, or the like; R.sup.4 represents hydrogen, methyl, benzyl, 3-isothiocyanatopropyl, or the like; and (R.sup.5).sub.m represents hydrogen, substituted benzo, or the like]. The compounds of the present invention have the excellent effect of preventing damage of the cerebral nerve cells. Therefore, the compounds of the present invention are useful as medicines used for curing and preventing various cerebral diseases such as cerebral stroke, traumatic cerebral diseases, cerebral edema, and cerebral neurodegenerative diseases, ameliorating aftereffects thereof, and preventing the recurrence thereof by inhibiting various ischemic, hemorrhagic or traumatic cerebral disorders, and damages of the cerebral nerve cells caused by various nerve degenerations.
    • PCT No.PCT / JP98 / 00092 Sec。 371日期:1998年9月24日 102(e)1998年9月24日PCT PCT 1998年1月13日PCT公布。 公开号WO98 / 31684 日期:1998年7月23日本发明提供吲哚并吗啡衍生物或其药理学上可接受的酸加成盐,以及由下式(I)表示的由其衍生物和盐组成的脑病的治疗和预防剂: 其中R1表示环丙基甲基等; R2和R3各自表示羟基甲氧基等; R4代表氢,甲基,苄基,3-异硫氰基丙基等; 和(R 5)m表示氢,取代的苯并或类似物]。 本发明的化合物具有防止脑神经细胞损伤的优异效果。 因此,本发明的化合物可用作治疗和预防各种脑疾病如脑中风,创伤性脑病,脑水肿和脑神经变性疾病的药物,改善其后遗症,并通过抑制各种缺血性疾病预防其复发 ,出血性或创伤性脑病,以及由各种神经变性引起的脑神经细胞损伤。
    • 2. 发明授权
    • Quinolinomorphinane derivatives and medicinal use thereof
    • 喹啉吗啡烷衍生物及其医药用途
    • US06172078B2
    • 2001-01-09
    • US09194538
    • 1999-01-13
    • Hiroshi NagaseYoshifumi ImamuraHiroshi OhnoMasanobu KaneedaSusumu MatsudaYasushi Miyauchi
    • Hiroshi NagaseYoshifumi ImamuraHiroshi OhnoMasanobu KaneedaSusumu MatsudaYasushi Miyauchi
    • C07D51500
    • C07D489/00
    • The present invention provides a quinolinomorphinan derivative or a pharmacologically acceptable acid addition salt thereof, and an agent for curing or preventing cerebral disorders composed of the derivative and salt thereof, which is represented by the following formula (I): (wherein R1 represents cyclopropylmethyl or the like; R2 and R3 independently represent hydroxy, methoxy, or the like; R4 represents hydrogen, methyl, amino or the like; and (R5)m represents hydrogen, substituted benzo, or the like. The compounds of the present invention prevent damages of the cerebral nerve cells and are useful as medicine for curing or preventing various cerebral diseases such as cerebral stroke, traumatic cerebral diseases, cerebral edema, and cerebral neurodegenerative diseases. The compounds of the present invention also ameliorate the after-effects of these diseases and prevent the recurrence of these diseases by inhibiting various ischemic, hemorrhagic or traumatic cerebral disorders, and damages of the cerebral nerve cells caused by various nerve degenerations.
    • 本发明提供喹啉吗啡喃衍生物或其药理学上可接受的酸加成盐,以及由下式(I)表示的用于治疗或预防由其衍生物和盐组成的脑病的药剂:(其中R1表示环丙基甲基或 R 2和R 3独立地表示羟基,甲氧基等; R 4表示氢,甲基,氨基等;(R 5)m表示氢,取代的苯并或类似物,本发明化合物可以防止损害 的脑神经细胞,可用作治疗或预防各种脑疾病如脑中风,创伤性脑疾病,脑水肿和脑神经变性疾病的药物,本发明的化合物还可以改善这些疾病的后遗症和 通过抑制各种缺血性,出血性或创伤性脑病,预防这些疾病的复发,以及d 大脑神经细胞由各种神经变性引起的药物。
    • 9. 发明授权
    • Initial crystallization method of recording media and device thereof
    • 记录介质的初始结晶方法及其装置
    • US06278680B1
    • 2001-08-21
    • US09275424
    • 1999-03-24
    • Yasushi MiyauchiEiji SahotaShin MatsumotoKazuhiro SogaMotoyasu Terao
    • Yasushi MiyauchiEiji SahotaShin MatsumotoKazuhiro SogaMotoyasu Terao
    • G11B712
    • G11B7/268G11B7/00557G11B7/26
    • An initial crystallization method of a recording medium such as a phase-change optical disk, which comprises forming a light spot composed of at least two flat elliptical beam spots each having a long axis direction and a short axis direction and irradiating a rotating recording medium with the light spot such that the long axis direction of the beam spots becomes other direction than the parallel direction to the track direction of the recording medium, wherein the above-described light spot has at least two peaks of light intensity in the short axis direction and the interval of said two peaks of light intensity is 10 &mgr;m or smaller but not smaller than 2 &mgr;m, and a device for carrying out the initial crystallization method. By the initial crystallization method and the device thereof, the initial crystallization of the recording film of the recording medium can be surely carried out at a high speed without causing non-uniformity.
    • 一种诸如相变光盘的记录介质的初始结晶方法,包括形成由至少两个具有长轴方向和短轴方向的平坦椭圆形光束点组成的光斑,并且将旋转记录介质照射 光斑使得光斑的长轴方向成为与记录介质的轨迹方向平行的方向以外的方向,其中上述光点在短轴方向上具有至少两个光强度的峰值,以及 所述两个光强度峰值的间隔为10μm或更小但不小于2μm,以及用于进行初始结晶方法的装置。通过初始结晶方法及其装置,记录膜的初始结晶 可以高速地可靠地进行记录介质,而不会引起不均匀。